Concepts (142)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lymphoma, Mantle-Cell | 1 | 2023 | 237 | 0.740 |
Why?
|
| Lymphoma, B-Cell | 1 | 2023 | 935 | 0.560 |
Why?
|
| Bone Marrow | 1 | 2024 | 2914 | 0.450 |
Why?
|
| Guanylate Cyclase | 1 | 2023 | 205 | 0.210 |
Why?
|
| CARD Signaling Adaptor Proteins | 1 | 2023 | 159 | 0.200 |
Why?
|
| Xenograft Model Antitumor Assays | 4 | 2018 | 3583 | 0.200 |
Why?
|
| Asparaginase | 1 | 2022 | 240 | 0.190 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2024 | 377 | 0.180 |
Why?
|
| Leukemia, B-Cell | 1 | 2020 | 84 | 0.180 |
Why?
|
| Leukocyte Elastase | 2 | 2011 | 114 | 0.160 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 2 | 2018 | 368 | 0.160 |
Why?
|
| Lymphoma, Extranodal NK-T-Cell | 1 | 2018 | 45 | 0.150 |
Why?
|
| Micro-Electrical-Mechanical Systems | 1 | 2016 | 31 | 0.140 |
Why?
|
| Bone Marrow Cells | 1 | 2024 | 2414 | 0.140 |
Why?
|
| Bone Marrow Transplantation | 1 | 2024 | 2693 | 0.130 |
Why?
|
| Lymphoma, T-Cell | 1 | 2018 | 305 | 0.130 |
Why?
|
| src-Family Kinases | 1 | 2018 | 535 | 0.130 |
Why?
|
| Tissue Banks | 1 | 2016 | 184 | 0.120 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 2018 | 545 | 0.120 |
Why?
|
| Neoplasms | 3 | 2017 | 22075 | 0.110 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2016 | 717 | 0.110 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2020 | 2829 | 0.110 |
Why?
|
| Neoplasm, Residual | 1 | 2018 | 1008 | 0.100 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2015 | 693 | 0.100 |
Why?
|
| Lab-On-A-Chip Devices | 1 | 2016 | 432 | 0.100 |
Why?
|
| Neoplasms, Experimental | 1 | 2016 | 1229 | 0.090 |
Why?
|
| Lymphoma, Follicular | 1 | 2015 | 453 | 0.090 |
Why?
|
| Agranulocytosis | 1 | 2011 | 99 | 0.090 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 2018 | 1378 | 0.090 |
Why?
|
| Escherichia coli | 1 | 2022 | 4219 | 0.090 |
Why?
|
| Hematologic Neoplasms | 1 | 2021 | 1901 | 0.080 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2021 | 3390 | 0.080 |
Why?
|
| Granulocytes | 1 | 2011 | 551 | 0.080 |
Why?
|
| Unfolded Protein Response | 1 | 2011 | 233 | 0.080 |
Why?
|
| Granulocyte Precursor Cells | 1 | 2007 | 49 | 0.070 |
Why?
|
| Leukemia | 1 | 2016 | 1523 | 0.070 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2018 | 2924 | 0.070 |
Why?
|
| Signal Transduction | 3 | 2020 | 23374 | 0.070 |
Why?
|
| B-Lymphocytes | 1 | 2020 | 4742 | 0.070 |
Why?
|
| Lymphoma | 1 | 2016 | 1899 | 0.070 |
Why?
|
| Practice Guidelines as Topic | 1 | 2024 | 7475 | 0.070 |
Why?
|
| Neutropenia | 2 | 2011 | 884 | 0.070 |
Why?
|
| Peptides | 1 | 2018 | 4354 | 0.070 |
Why?
|
| Antineoplastic Agents | 3 | 2018 | 13627 | 0.060 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2018 | 4496 | 0.060 |
Why?
|
| Ambulatory Care | 1 | 2016 | 2782 | 0.060 |
Why?
|
| Nuclear Proteins | 1 | 2018 | 5795 | 0.050 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2018 | 8512 | 0.050 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2018 | 5640 | 0.050 |
Why?
|
| Humans | 15 | 2024 | 760613 | 0.050 |
Why?
|
| Blood Cell Count | 1 | 2021 | 398 | 0.050 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 6 | 1 | 2020 | 120 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-bcl-6 | 1 | 2020 | 191 | 0.040 |
Why?
|
| STAT5 Transcription Factor | 1 | 2020 | 264 | 0.040 |
Why?
|
| Immunotherapy | 1 | 2015 | 4642 | 0.040 |
Why?
|
| Mice | 7 | 2022 | 81209 | 0.040 |
Why?
|
| Imidazolines | 1 | 2018 | 18 | 0.040 |
Why?
|
| Depsipeptides | 1 | 2018 | 95 | 0.040 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2020 | 616 | 0.040 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2015 | 9278 | 0.040 |
Why?
|
| Genes, myc | 1 | 2018 | 395 | 0.030 |
Why?
|
| Ikaros Transcription Factor | 1 | 2018 | 231 | 0.030 |
Why?
|
| Emergency Service, Hospital | 1 | 2016 | 7818 | 0.030 |
Why?
|
| Rabbits | 1 | 2022 | 4773 | 0.030 |
Why?
|
| Leukemia, Experimental | 1 | 2016 | 225 | 0.030 |
Why?
|
| Databases as Topic | 1 | 2017 | 474 | 0.030 |
Why?
|
| Chromosome Aberrations | 1 | 2021 | 1767 | 0.030 |
Why?
|
| Janus Kinase 2 | 1 | 2018 | 542 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2020 | 995 | 0.030 |
Why?
|
| Drug Therapy | 1 | 2018 | 504 | 0.030 |
Why?
|
| Antibodies | 1 | 2022 | 2421 | 0.030 |
Why?
|
| Isoquinolines | 1 | 2016 | 353 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 2020 | 3602 | 0.030 |
Why?
|
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2016 | 223 | 0.030 |
Why?
|
| Equipment Failure Analysis | 1 | 2016 | 848 | 0.030 |
Why?
|
| Animals | 7 | 2022 | 167960 | 0.030 |
Why?
|
| Genes, p53 | 1 | 2016 | 713 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2011 | 11481 | 0.030 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2018 | 685 | 0.030 |
Why?
|
| Vincristine | 1 | 2015 | 1038 | 0.030 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2018 | 1347 | 0.030 |
Why?
|
| Cell Line, Tumor | 2 | 2020 | 16932 | 0.030 |
Why?
|
| Disease Models, Animal | 3 | 2018 | 18137 | 0.030 |
Why?
|
| Adenine | 1 | 2018 | 975 | 0.030 |
Why?
|
| Remission Induction | 1 | 2018 | 2392 | 0.030 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2018 | 5251 | 0.030 |
Why?
|
| Neoplasm Transplantation | 1 | 2016 | 2014 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2016 | 1837 | 0.020 |
Why?
|
| Random Allocation | 1 | 2016 | 2394 | 0.020 |
Why?
|
| Apoptosis | 1 | 2007 | 9497 | 0.020 |
Why?
|
| Patients | 1 | 2017 | 906 | 0.020 |
Why?
|
| Prednisone | 1 | 2015 | 1566 | 0.020 |
Why?
|
| Cyclophosphamide | 1 | 2015 | 2222 | 0.020 |
Why?
|
| Piperidines | 1 | 2018 | 1650 | 0.020 |
Why?
|
| Mutant Proteins | 1 | 2011 | 492 | 0.020 |
Why?
|
| Doxorubicin | 1 | 2015 | 2208 | 0.020 |
Why?
|
| Equipment Design | 1 | 2016 | 3520 | 0.020 |
Why?
|
| Mutation | 2 | 2015 | 29957 | 0.020 |
Why?
|
| Pyrazoles | 1 | 2018 | 1999 | 0.020 |
Why?
|
| Protein Denaturation | 1 | 2007 | 242 | 0.020 |
Why?
|
| Cell Lineage | 1 | 2016 | 2532 | 0.020 |
Why?
|
| Myelopoiesis | 1 | 2007 | 134 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 2018 | 3448 | 0.020 |
Why?
|
| Proteome | 1 | 2016 | 1855 | 0.020 |
Why?
|
| Protein Binding | 1 | 2018 | 9335 | 0.020 |
Why?
|
| Pyrimidines | 1 | 2018 | 3016 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2022 | 7850 | 0.020 |
Why?
|
| Treatment Outcome | 3 | 2018 | 64981 | 0.020 |
Why?
|
| Piperazines | 1 | 2016 | 2525 | 0.020 |
Why?
|
| Gene Expression | 1 | 2018 | 7587 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2015 | 6831 | 0.020 |
Why?
|
| Molecular Targeted Therapy | 1 | 2016 | 2803 | 0.010 |
Why?
|
| Medical Oncology | 1 | 2016 | 2313 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2016 | 10826 | 0.010 |
Why?
|
| Neoplasm Proteins | 1 | 2016 | 3612 | 0.010 |
Why?
|
| Internet | 1 | 2016 | 3078 | 0.010 |
Why?
|
| Protein Folding | 1 | 2007 | 867 | 0.010 |
Why?
|
| Critical Care | 1 | 2016 | 2699 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2016 | 8556 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2018 | 14374 | 0.010 |
Why?
|
| Length of Stay | 1 | 2016 | 6476 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2016 | 18955 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2016 | 10442 | 0.010 |
Why?
|
| Female | 5 | 2020 | 391246 | 0.010 |
Why?
|
| Research Design | 1 | 2016 | 6180 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2016 | 9406 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2016 | 10343 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2011 | 9530 | 0.010 |
Why?
|
| Phenotype | 1 | 2016 | 16548 | 0.010 |
Why?
|
| Male | 4 | 2016 | 359718 | 0.010 |
Why?
|
| Hospitalization | 1 | 2016 | 10789 | 0.010 |
Why?
|
| Prognosis | 1 | 2015 | 29661 | 0.010 |
Why?
|
| Aged | 2 | 2016 | 169143 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2011 | 22020 | 0.010 |
Why?
|
| Middle Aged | 2 | 2016 | 220359 | 0.010 |
Why?
|
| Adult | 2 | 2016 | 220007 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2016 | 58980 | 0.010 |
Why?
|
| Young Adult | 1 | 2016 | 58748 | 0.010 |
Why?
|
| Pregnancy | 1 | 2011 | 29746 | 0.010 |
Why?
|
| Risk Factors | 1 | 2015 | 74333 | 0.000 |
Why?
|
| Adolescent | 1 | 2016 | 87809 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 2015 | 80345 | 0.000 |
Why?
|
Concepts
(142)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(66)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_